Monte Rosa Therapeutics, Inc.
GLUE
DELAYED 1 MONTH
8 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2 8:05 PM | Markus WarmuthDirector, President & CEO | Sale | 5,466 | $19.44 | $106.3K | 594,538(D) | View → |
| May 29, 2026 | Jun 1 8:05 PM | Sharon TownsonChief Scientific Officer | Sale | 6,000 | $19.87 | $119.2K | 67,845(D) | View → |
| May 27, 2026 | May 28 11:10 PM | Jennifer ChampouxChief Operating Officer | Sale | 2,175 | $20.00 | $43.5K | 62,371(D) | View → |
| May 22, 2026 | May 26 8:05 PM | Jennifer ChampouxChief Operating Officer | Sale | 2,176 | $19.00 | $41.3K | 62,371(D) | View → |
| May 21, 2026 | May 22 8:05 PM | Anthony M. ManningDirector | Sale | 10,000 | $18.01 | $180.1K | 0(D) | View → |
| May 1, 2026 | May 5 8:05 PM | Markus WarmuthDirector, President & CEO | Sale | 5,467 | $18.92 | $103.4K | 600,004(D) | View → |
| Mar 4, 2026 | Mar 5 10:24 PM | Edmund DunnPrincipal Accounting Officer | Sale | 139 | $17.96 | $2.5K | 22,554(D) | View → |
| Mar 2, 2026 | Mar 4 9:50 PM | Markus WarmuthDirector, President & CEO | Sale | 5,466 | $17.92 | $98.0K | 613,471(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Jun 1 8:05 PM | Sharon TownsonChief Scientific Officer | Option Exercise | 6,000 | $6.14 | 209,290(D) | View → |
| May 27, 2026 | May 28 11:10 PM | Jennifer ChampouxChief Operating Officer | Option Exercise | 2,175 | $3.98 | 35,649(D) | View → |
| May 22, 2026 | May 26 8:05 PM | Jennifer ChampouxChief Operating Officer | Option Exercise | 2,176 | $3.98 | 37,824(D) | View → |
| May 21, 2026 | May 22 8:05 PM | Anthony M. ManningDirector | Option Exercise | 10,000 | $4.16 | 12,100(D) | View → |